comparemela.com

Page 8 - George Apostol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NLS Pharmaceutics AG: NLS Pharmaceutics To Host Virtual Key Opinion Leader Event on September 30, 2022 After Release of Quilience Top-Line Phase 2a Narcolepsy Results

ZURICH, SWITZERLAND / ACCESSWIRE / September 19, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP), (Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery

United statesAlex zwyerBruce corserAnne marie morseGeorge apostolCindy rizzoPascal nigenNovant healthGeisinger medical centerPharmaceutics ltdExchange commissionAlpha bronzeManagement instituteEuropean medicines agencyVirtual key opinion leaderChief medical officer

NLS Pharmaceutics To Host Virtual Key Opinion Leader Event on September 30, 2022 After Release of Quilience(R) Top-Line Phase 2a Narcolepsy Results

NLS Pharmaceutics To Host Virtual Key Opinion Leader Event on September 30, 2022 After Release of Quilience(R) Top-Line Phase 2a Narcolepsy Results
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

United statesAlex zwyerBruce corserAnne marie morseGeorge apostolCindy rizzoPascal nigenNovant healthGeisinger medical centerPharmaceutics ltdExchange commissionAlpha bronzeManagement instituteEuropean medicines agencyVirtual key opinion leaderChief medical officer

NLS Pharmaceutics Appoints Dr George Apostol as Chief Medical Officer and Global Head of Research & Development

NLS Pharmaceutics Appoints Dr George Apostol as Chief Medical Officer and Global Head of Research & Development
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

United statesAlex zwyerGeorge apostolCindy rizzoPascal nigenSylvia panigoneEndo pharmaceuticals incHead of global researchEli lilly coPharmaceutics ltdCarol davila medical schoolExchange commissionGlobal head of researchAlpha bronzeClinical researchUniversity of minnesota

NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Dr George Apostol as Chief Medical Officer and Global Head of Research & Development

Company also announces expected departure of Sylvia Panigone, Ph.D.ZURICH, SWITZERLAND / ACCESSWIRE / September 8, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage

United statesAlex zwyerGeorge apostolCindy rizzoPascal nigenSylvia panigoneEndo pharmaceuticals incHead of global researchEli lilly coPharmaceutics ltdCarol davila medical schoolExchange commissionGlobal head of researchAlpha bronzeClinical researchUniversity of minnesota

Elastics cloud Raises Additional $17M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesGeorge apostolSmart interconnect technologySan joseSmart interconnectCompute express link

vimarsana © 2020. All Rights Reserved.